A research team led by Prof Leung Chung Hang in the Institute of Chinese Medical Sciences (ICMS), University of Macau (UM), and another research team led by Prof Ma Dik Lung in the Department of Chemistry, Hong Kong Baptist University (HKBU), have successfully synthesised a new gastrin-releasing peptide receptor (GRPr)-based probe to integrate cancer treatment and diagnosis. The probe can selectively visualise GRPr in living cancer cells while modulating the function of GRPr in immune cells, which will help to accurately identify tumours and their biological characteristics. The study has been published in the internationally renowned journal Angewandte Chemie International Edition.
